Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais Opções

Ativos Totais de Vaxcyte, Inc..

Dados anuais

2019

2020

2021

2022

2023

2024

‪0,00‬

‪‪900,00 M‬‬

‪‪1,80 B‬‬

‪‪2,70 B‬‬

‪‪3,60 B‬‬

Período

Valor

Variação

Variação %

2024

‪‪3,53 B‬‬

+‪‪2,13 B‬‬

+‪150,96‬%

2023

‪‪1,41 B‬‬

+‪‪401,74 M‬‬

+‪39,93‬%

2022

‪‪1,01 B‬‬

+‪‪681,84 M‬‬

+‪210,23‬%

2021

‪‪324,34 M‬‬

‪‪−68,49 M‬‬

‪−17,43‬%

2020

‪‪392,83 M‬‬

+‪‪327,13 M‬‬

+‪497,93‬%

2019

Dados trimestrais

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0,00‬

‪‪900,00 M‬‬

‪‪1,80 B‬‬

‪‪2,70 B‬‬

‪‪3,60 B‬‬

Período

Valor

Variação

Variação %

Q4 '24

‪‪3,53 B‬‬

‪‪−26,45 M‬‬

‪−0,74‬%

Q3 '24

‪‪3,56 B‬‬

+‪‪1,47 B‬‬

+‪70,55‬%

Q2 '24

‪‪2,09 B‬‬

‪‪−4,04 M‬‬

‪−0,19‬%

Q1 '24

‪‪2,09 B‬‬

+‪‪683,39 M‬‬

+‪48,54‬%

Q4 '23

‪‪1,41 B‬‬

‪‪−88,14 M‬‬

‪−5,89‬%

Q3 '23

‪‪1,50 B‬‬

‪‪−6,76 M‬‬

‪−0,45‬%

Q2 '23

‪‪1,50 B‬‬

+‪‪494,66 M‬‬

+‪49,07‬%

Q1 '23

‪‪1,01 B‬‬

+‪‪1,99 M‬‬

+‪0,20‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19